A detailed history of Peregrine Capital Management LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 102,926 shares of LNTH stock, worth $9.19 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
102,926
Previous 189,721 45.75%
Holding current value
$9.19 Million
Previous $15.2 Million 25.84%
% of portfolio
0.35%
Previous 0.46%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$77.7 - $123.62 $6.74 Million - $10.7 Million
-86,795 Reduced 45.75%
102,926 $11.3 Million
Q2 2024

Jul 29, 2024

SELL
$58.87 - $83.05 $38,324 - $54,065
-651 Reduced 0.34%
189,721 $15.2 Million
Q1 2024

Apr 26, 2024

SELL
$51.07 - $68.26 $582,657 - $778,778
-11,409 Reduced 5.65%
190,372 $11.8 Million
Q4 2023

Jan 26, 2024

SELL
$55.6 - $77.89 $3.69 Million - $5.17 Million
-66,329 Reduced 24.74%
201,781 $12.5 Million
Q3 2023

Oct 19, 2023

BUY
$60.27 - $90.75 $1.24 Million - $1.87 Million
20,554 Added 8.3%
268,110 $18.6 Million
Q2 2023

Jul 26, 2023

SELL
$82.41 - $99.65 $843,136 - $1.02 Million
-10,231 Reduced 3.97%
247,556 $20.8 Million
Q1 2023

Apr 26, 2023

SELL
$47.76 - $82.86 $565,287 - $980,730
-11,836 Reduced 4.39%
257,787 $21.3 Million
Q4 2022

Jan 10, 2023

BUY
$48.76 - $77.67 $2.8 Million - $4.45 Million
57,355 Added 27.02%
269,623 $13.7 Million
Q3 2022

Oct 26, 2022

SELL
$61.42 - $86.29 $34,886 - $49,012
-568 Reduced 0.27%
212,268 $14.9 Million
Q2 2022

Jul 20, 2022

SELL
$55.54 - $72.65 $170,007 - $222,381
-3,061 Reduced 1.42%
212,836 $14.1 Million
Q1 2022

Apr 27, 2022

SELL
$24.28 - $56.64 $11.9 Million - $27.7 Million
-489,931 Reduced 69.41%
215,897 $11.9 Million
Q4 2021

Jan 31, 2022

SELL
$22.54 - $30.44 $2.93 Million - $3.96 Million
-130,125 Reduced 15.57%
705,828 $20.4 Million
Q3 2021

Nov 02, 2021

SELL
$24.23 - $28.59 $4.18 Million - $4.93 Million
-172,376 Reduced 17.1%
835,953 $21.5 Million
Q2 2021

Aug 03, 2021

SELL
$19.51 - $27.64 $2.07 Million - $2.93 Million
-106,181 Reduced 9.53%
1,008,329 $27.9 Million
Q1 2021

May 11, 2021

SELL
$13.77 - $21.66 $547,880 - $861,808
-39,788 Reduced 3.45%
1,114,510 $23.8 Million
Q4 2020

Jan 19, 2021

BUY
$10.75 - $14.91 $6.95 Million - $9.64 Million
646,803 Added 127.45%
1,154,298 $15.6 Million
Q3 2020

Oct 20, 2020

BUY
$11.98 - $16.34 $915,487 - $1.25 Million
76,418 Added 17.73%
507,495 $6.43 Million
Q2 2020

Jul 30, 2020

BUY
$10.34 - $15.51 $63,301 - $94,952
6,122 Added 1.44%
431,077 $6.16 Million
Q1 2020

Apr 17, 2020

BUY
$9.11 - $20.05 $1.91 Million - $4.2 Million
209,454 Added 97.19%
424,955 $5.42 Million
Q4 2019

Jan 16, 2020

SELL
$18.47 - $24.03 $9,087 - $11,822
-492 Reduced 0.23%
215,501 $4.42 Million
Q3 2019

Oct 16, 2019

SELL
$21.01 - $28.94 $1.96 Million - $2.7 Million
-93,435 Reduced 30.2%
215,993 $5.41 Million
Q2 2019

Jul 18, 2019

SELL
$23.33 - $28.3 $10.2 Million - $12.4 Million
-438,269 Reduced 58.62%
309,428 $0
Q1 2019

Apr 12, 2019

SELL
$14.93 - $25.1 $1.33 Million - $2.24 Million
-89,411 Reduced 10.68%
747,697 $0
Q4 2018

Jan 17, 2019

BUY
$12.68 - $19.01 $3.42 Million - $5.12 Million
269,334 Added 47.44%
837,108 $13.1 Million
Q3 2018

Oct 18, 2018

SELL
$13.1 - $16.35 $112,293 - $140,152
-8,572 Reduced 1.49%
567,774 $0
Q2 2018

Jul 12, 2018

SELL
$13.65 - $18.7 $632,513 - $866,520
-46,338 Reduced 7.44%
576,346 $0
Q1 2018

Apr 16, 2018

BUY
$14.85 - $24.3 $3 Million - $4.92 Million
202,312 Added 48.13%
622,684 $0
Q4 2017

Jan 24, 2018

SELL
$17.4 - $23.4 $566,196 - $761,436
-32,540 Reduced 7.18%
420,372 $0
Q3 2017

Oct 25, 2017

BUY
$15.5 - $19.15 $7.02 Million - $8.67 Million
452,912
452,912 $0

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.